Jubilant Innovation Ltd.   Report issue

Contributed to NME For profit Phase 2
Founded: Nolda India (1978)

Organization Overview

First Clinical Trial
2009
NCT00842335
First Marketed Drug
1978
wasp venom protein
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

JUBILANT CADISTA | JUBILANT GENERICS | Jubilant HollisterStier LLC